|CRDAMC Homepage | CRDAMC Library Phone #: (254) 288-8366 | CRDAMC Library Fax #: (254) 288-8368|
August 02, 2017
Know the Signs of Concussion
WEDNESDAY, Aug. 2, 2017 (HealthDay News) -- Concussions have been in the news a lot because of health problems experienced by football players, but you don't have to be a professional athlete to suffer this injury.
Health Tip: Can't Clear Your Acne?
(HealthDay News) -- If you're having little success in clearing your acne, experts say you shouldn't give up hope.
Health Tip: Cooling a Heat Rash
(HealthDay News) -- Heat rash describes the bumpy, itchy skin that develops during hot and humid weather.
Traveling With Dementia: Tips for Family Caregivers
WEDNESDAY, Aug. 2, 2017 (HealthDay News) -- Traveling with a loved one who has dementia requires special preparation. The Alzheimer's Foundation of America has some advice.
Do Your Pearly Whites Sometimes Cause You Pain?
TUESDAY, Aug. 1, 2017 (HealthDay News) -- Do you feel a sharp pain when you eat or drink something cold or hot? You may have sensitive teeth, a common problem caused by a number of factors.
Combined MRI Might Help Predict Brain Damage in Boxers
WEDNESDAY, Aug. 2, 2017 (HealthDay News) -- Brain injuries among pro football players are in the headlines, but pro fighters often suffer damaging head injuries, too.
10 Factors to Predict Bleeding Risk in Stroke Survivors
WEDNESDAY, Aug. 2, 2017 (HealthDay News) -- Stroke survivors at high risk for bleeding from drugs meant to prevent another stroke can be identified using a new scoring system, new research contends.
Less Than Half of U.S. Stroke Patients Get Rx for Statins
WEDNESDAY, Aug. 2, 2017 (HealthDay News) -- Fewer than half of U.S. stroke survivors are prescribed cholesterol-lowering statins, a new study finds.
Stopping Statins After Stroke May Raise Risk of Another
WEDNESDAY, Aug. 2, 2017 (HealthDay News) -- Stroke survivors who stop taking cholesterol-lowering statins are at increased risk for another stroke, a new study finds.
Medical Reality Catches Up to Science Fiction
TUESDAY, Aug. 1, 2017 (HealthDay News) -- Average folks may one day be able to use a Star Trek-inspired home medical device to diagnose a dozen different ailments and track five major vital signs, all without needing to draw blood or visit a doctor's office.
Scientists Gain Insight Into Allergies
WEDNESDAY, Aug. 2, 2017 (HealthDay News) -- Scientists report they've pinpointed which immune system cells trigger allergies.
Health Highlights: Aug. 2, 2017
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
2 of 3 U.S. Patients Keep Unused Painkillers After Surgery
WEDNESDAY, Aug. 2, 2017 (HealthDay News) -- Surgery patients are usually prescribed opioids to ease postoperative pain, but more than two-thirds end up with leftover narcotics and don't get rid of them, according to a new report.
Novel Procedure Improves Kidney Transplant Success
WEDNESDAY, Aug. 2, 2017 (HealthDay News) -- A new treatment might open the door for more patients with advanced kidney disease to get a transplant, a preliminary study suggests.
Geneticists Repair Mutation in Human Embryo
WEDNESDAY, Aug. 2, 2017 (HealthDay News) -- In a first-ever experiment, geneticists have successfully modified a human embryo to remove a mutation that causes a life-threatening heart condition.
Is Infant Drug Withdrawal Likelier When Opioids Used With Psychiatric Drugs?
WEDNESDAY, Aug. 2, 2017 (HealthDay News) -- More U.S. babies go through drug withdrawal after birth these days, and researchers say doctors' prescribing practices are partly to blame.
Doctors May Be Over-Prescribing Seizure Drugs to Treat Pain
WEDNESDAY, Aug. 2, 2017 (HealthDay News) -- Physicians might be relying too heavily on "off-label" use of epilepsy drugs as an alternative to prescribing narcotic painkillers, two experts in internal medicine contend.
Imbruvica Approval Expanded to Include Graft Versus Host Disease
WEDNESDAY, Aug. 2, 2017 (HealthDay News) -- The U.S. Food and Drug Administration on Wednesday expanded approval for the anti-cancer drug Imbruvica (ibrutinib) to include adults with chronic graft versus host disease (cGVHD).
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at firstname.lastname@example.org. Our Health Library Support team will respond to your email request within 2 business days.